Evolution of Six-Month Post-COVID Symptom Risk in France During 2020

Overview

This national population-based cohort study in France found that the risk of six-month post-COVID symptoms was significantly higher during the first epidemic wave (March-May 2020) compared to the second wave (September-November 2020). The risk was influenced by baseline physical and mental health conditions, sex, and educational level, with notable differences between the two periods.

Background

Post-COVID symptoms, also known as long COVID, can persist for months after acute SARS-CoV-2 infection and impact daily functioning. The risk estimates vary widely due to differences in study designs, populations, and definitions. Factors such as sex, age, severity of acute illness, and preexisting comorbidities have been associated with increased risk. Temporal changes in risk may reflect evolving healthcare, public health measures, and viral variants, but data prior to vaccine availability and variant spread remain limited.

Data Highlights

Key Findings

• The six-month post-COVID symptom risk was 14.6% during the first wave versus 7.0% during the second wave in 2020.
• Adjusted relative risk of post-COVID symptoms was 1.36 times higher for infections during the first wave compared to the second.
• Risk increased with the number of acute COVID symptoms and presence of baseline physical conditions in both periods.
• During the first wave, women and individuals with baseline mental health conditions had higher risk; educational level also influenced risk.
• The observed temporal difference occurred before the emergence of SARS-CoV-2 variants and vaccine availability.

Clinical Implications

Clinicians should be aware that the risk of long-term post-COVID symptoms may vary depending on the timing of infection within the pandemic context, influenced by healthcare access and public health measures. Attention to patients’ baseline physical and mental health status, as well as sociodemographic factors, is important for risk stratification and management of post-COVID sequelae.

Conclusion

The study demonstrates a higher risk of six-month post-COVID symptoms during the initial pandemic wave in France, highlighting the impact of contextual factors on long COVID risk prior to variant emergence and vaccination. These findings underscore the need to consider temporal and individual factors in post-COVID care.

References

1. EpiCov Cohort Study 2024 -- Evolution of Six-Month Post-COVID Symptom Risk